Layer, Chiang, et al. Genome Biology
Waters CEO Hints at New Platform, 'Exciting' Year for Mass Spec Business in 2010
In the midst of reporting a 3 percent revenue increase for Waters fourth quarter, CEO Douglas Berthiaume said a planned new quadrupole instrument launch, shipping of its Synapt G2 instrument, and mass spec-based stimulus grants could portend a strong year for the company's mass spec business.
New to GenomeWeb? Register here quickly.